Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-04-24

Clinical Trial Update: The Effect of Donepezil (Aricept(Registered Trademark)) on REM Sleep in Children With Autism [Phase 1, Phase 2]

View source ↗

Summary

Results from an NIMH-sponsored Phase 1/2 trial evaluate the effect of donepezil (Aricept) on REM sleep in children with autism and cognitive disorders; results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aricept (Donepezil)

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Autism, Cognition Disorder | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2013-04-24